Metacarpal cortical area and risk of coronary heart disease - The Framingham Study

被引:92
|
作者
Samelson, EJ
Kiel, DP
Broe, KE
Zhang, YQ
Cupples, LA
Hannan, MT
Wilson, PWF
Levy, D
Williams, SA
Vaccarino, V
机构
[1] Hebrew Rehabil Ctr Aged, Res & Training Inst, Boston, MA 02131 USA
[2] Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA
[3] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA
[4] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[6] Framingham Heart Dis Epidemiol Study, Boston, MA USA
[7] NHLBI, Bethesda, MD 20892 USA
[8] AstraZeneca LP, Wilmington, DE USA
[9] Emory Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
[10] Rollins Sch Publ Hlth, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
bone and bones; coronary disease; incidence; osteoporosis; prospective studies;
D O I
10.1093/aje/kwh080
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The objective of this study was to determine the relation between bone mass and the incidence of coronary heart disease in women and men. Participants included 2,059 cohort members of the Framingham Study (1,236 women and 823 men aged 47-80 years) who underwent posteroanterior hand radiography and were free from cardiovascular disease at baseline (1967-1970) and who were then followed for 30 years through the end of 1997 for the incidence of coronary heart disease. The incidence of coronary heart disease decreased from 15.65/1,000 person-years among women in the lowest metacarpal cortical area quartile to 11.76/1,000 person-years among women in the highest quartile (p(trend) = 0.03), and the inverse relation persisted after adjustment for confounders (highest vs. lowest quartile of metacarpal cortical area: hazard ratio = 0.73, 95% confidence interval: 0.53, 1.00; p(trend) = 0.03). In contrast, no association was present in men (highest vs. lowest quartile of metacarpal cortical area: hazard ratio = 1.14, 95% confidence interval: 0.84, 1.56; p(trend) = 0.55).
引用
收藏
页码:589 / 595
页数:7
相关论文
共 50 条
  • [1] Obesity and risk for coronary heart disease: The Framingham Heart Study
    Wilson, PWF
    Ho, B
    D'Agostino, RBD
    OBESITY RESEARCH, 2000, 8 : 40S - 40S
  • [2] LIPOPROTEINS AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY
    CASTELLI, WP
    KANNEL, WB
    SHURTLEF.D
    CIRCULATION, 1966, 34 (4S3) : I71 - &
  • [3] BLOOD PRESSURE AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY
    KANNEL, WB
    SCHWARTZ, MJ
    MCNAMARA, PM
    DISEASES OF THE CHEST, 1969, 56 (01): : 43 - +
  • [4] TYPE OF HYPERCHOLESTEROLEMIA AND RISK OF CORONARY HEART DISEASE . FRAMINGHAM STUDY
    KANNEL, WB
    CASTELLI, WP
    MCNAMARA, PM
    AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (01): : 120 - &
  • [5] SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY
    KANNEL, WB
    CASTELLI, WP
    GORDON, T
    MCNAMARA, PM
    ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) : 1 - +
  • [6] PHYSICAL ACTIVITY AND RISK OF FATAL CORONARY HEART DISEASE - FRAMINGHAM STUDY
    KANNEL, WB
    MCNAMARA, PM
    CIRCULATION, 1967, 36 (4S2) : I154 - &
  • [7] Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study
    Franklin, SS
    Khan, SA
    Wong, ND
    Larson, MG
    Levy, D
    CIRCULATION, 1999, 100 (04) : 354 - 360
  • [8] Framingham risk score and lifetime risk of coronary heart disease
    Lloyd-Jones, DM
    Larson, MG
    Beiser, A
    Leip, E
    D'Agostino, RB
    Wilson, PW
    Levy, D
    CIRCULATION, 2000, 102 (18) : 842 - 842
  • [9] Lifetime risk of developing coronary heart disease by sex and age in the Framingham Heart Study
    Lloyd-Jones, DM
    Larson, MG
    Beiser, A
    Levy, D
    CIRCULATION, 1998, 98 (17) : 96 - 97
  • [10] Treatment with sibutramine reduces the risk of coronary heart disease - Application of the Framingham Heart Study
    Lauterbach, KW
    Evers, T
    Shepherd, G
    Chong, E
    OBESITY RESEARCH, 2001, 9 : 153S - 153S